%PDF-1.4
%
19 0 obj
<>
endobj
16 0 obj
<>
endobj
62 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-03-05T14:55:18Z
2024-03-29T03:29:32-07:00
QuarkXPressª 4.11: AdobePS 8.6 (219)
2024-03-29T03:29:32-07:00
application/pdf
Heather
2002-936.omeract.april
uuid:e3440fc0-1dd1-11b2-0a00-c808275d6100
uuid:e3440fc2-1dd1-11b2-0a00-aa0000000000
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
20 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
68 0 obj
[72 0 R]
endobj
69 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.1192 Tw 10 0 0 10 54 713.1616 Tm
[(was a bonus. )17.8 (W)79.9 (e were encouraged by the response to our)]TJ
-0.0163 Tw 0 -1.2 TD
[(participation and hope that future OMERACT)-216 (meetings will)]TJ
0.02499 Tw T*
(continue to involve patients.)Tj
0 -2.4 TD
[(ENID QUEST)73.9 (, UK, for the Patient Perspective Group:)]TJ
0 -1.2 TD
[(GERD JENNY)-183.3 (AANERUD, Norway; SYL)91.7 (VIA)-220.2 (KAARUD,)]TJ
-0.0298 Tw T*
[(Norway; )-54.8 (SHIRLEY)-238.3 (COLLINS, Australia; AMYE )-54.8 (LEONG,)]TJ
0.02499 Tw T*
[(USA)-220.2 (and France; BIRGITT)79.7 (A)-220.1 (SMEDEBY)128.8 (, Sweden;)]TJ
T*
[(ANNE DENNY)110.7 (-W)110.7 (A)110.8 (TERS, )54.8 (Australia; RA)91.7 (YMOND)]TJ
T*
[(MELLORS, UK; DEBORAH )17.7 (T)79.9 (A)91.8 (YLOR, UK; )]TJ
0.00729 Tw T*
[(MAAR)59.7 (TEN )-17.7 (de WIT)73.9 (, The )-17.7 (Netherlands.)]TJ
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 54 571.1616 Tm
[(Addr)36.8 (ess r)36.8 (eprint r)36.8 (equests to Mrs. E. Quest, c/o Rheumatology Unit,)]TJ
0.0161 Tw 0 -1.25 TD
[(University of Bristol Division of Medicine, Bristol Royal Infirmary)55 (, Bristol)]TJ
0.02499 Tw T*
[(BS2 8HW)91.7 (, United Kingdom.)]TJ
ET
0 0 0 0 scn
420 777 137 -27 re
f*
408 770 150 -25 re
f*
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
0 0 0 1 scn
/T1_1 1 Tf
8 0 0 8 54.5 35.9844 Tm
[(Quest, et al: Patients\325)-164.3 (perspective)]TJ
0 Tc 0 Tw 61.4375 -0.0313 Td
(885)Tj
ET
0 0 0 0 scn
/GS0 gs
109.22 59.09 396.48 -10.84 re
f*
0.5 w
109.22 59.09 396.48 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
26 0 obj
<>
endobj
29 0 obj
<>
endobj
57 0 obj
<>
endobj
67 0 obj
<>
endobj
31 0 obj
<>
endobj
52 0 obj
<>stream
HS{PSg˽QFͭک c!`""VY^B@ [ "`VRE-Z|ڵu]lM?wvڑsgw~\